Dr Kiran Mazumdar-Shaw named as Victorian Business Ambassador

2018-03-21 06:32:17

The Australian state of Victoria has launched a drive to strengthen its trade and investment ties with India with the appointment of Dr Kiran Mazumdar-Shaw as the Victorian Business Ambassador.By Team ABLEThe Australian state of Victoria has launched a drive to strengthen its trade and investment ties with India with the appointment of Dr Kiran Mazumdar-Shaw as the Victorian Business Ambassador.Ea

Read more

Kalam Institute of Health Technology successfully hosts Eighth International Fellowship on Health Technology Assessment

2018-03-21 06:30:22

KIHT hosted the Eighth International Fellowship on Health Technology Assessment in Visakhapatnam By Team ABLEFor spreading better understanding of Health Technology Assessment (HTA) among innovators and manufactures, Kalam Institute of Health Technology (KIHT) hosted the Eighth International Fellowship on Health Technology Assessment (HTA) in Visakhapatnam from March 05-09, 2018. The program was a

Read more

Microsoft & Apollo Hospitals to use Artificial Intelligence for early detection of cardiac diseases

2018-03-21 06:29:22

The partnership between Microsoft and Apollo will work to develop and deploy new machine learning models to predict patient risk for heart diseaseBy Team ABLEAt the Healthcare Information and Management Systems Society (HIMSS) annual conference and exhibition in Las Vegas, NV, Microsoft announced the expansion of the Microsoft Intelligent Network for eyecare (MINE), now AI Network for Healthcare,

Read more

Zydus\' first branded product launched in USA

2018-03-21 06:26:39

Zydus partners with Medicure to launch its NDA product, ZYPITAMAG (pitavastatin) in the U.S. By Team ABLEZydus Cadila has entered into a definitive agreement with Medicure International Inc., a subsidiary of Medicure Inc. (Medicure) to commercialize its 505(b)(2) New Drug Application (NDA) product, pitavastatin magnesium (ZYPITAMAGTM) in the United States. The launch of ZYPITAMAG, which is used to

Read more

Guided Therapeutics’ LuViva device achieves regulatory approval for sale in India

2018-03-21 06:25:01

LuViva is a device that scans the cervix with light and uses spectroscopy for cervical cancer diagnosis.By Team ABLEGuided Therapeutics Inc. has received Regulatory Approval from the Indian Ministry of Health & Family Welfare to allow commercialization of the LuViva device and disposables. The Ministry concluded that the LuViva device is “Non Invasive” and as such is “not regulated under

Read more

Biogen pays $75 million to buy Pfizer’s neuropsychiatry drug asset

2018-03-21 06:24:08

Biogen will acquire PF-04958242, a first-in-class, Phase 2b ready AMPA receptor potentiator for cognitive impairment associated with schizophrenia from Pfizer. By Team ABLENasdaq-listed pharma giant Biogen Inc. has signed an agreement to acquire PF-04958242, a first-in-class, Phase 2b ready AMPA receptor potentiator for cognitive impairment associated with schizophrenia (CIAS) from Pfizer Inc. The

Read more

International Council of Biotech Associations unveils new website

2018-03-21 06:22:23

The new website aims to unite publicly available resources of ICBA members, providing a virtual library of materials ranging from economic and employment data to issue specific whitepapers. By Team ABLEThe International Council of Biotech Associations (ICBA), in which ABLE is an active member, has announced the launch of its internationalbiotech.org, a new website to support the organization’s m

Read more

Novartis expands alliance with Science 37 to advance virtual clinical trials program

2018-03-11 23:46:47

Novartis and Science 37 commit to launch up to 10 trials with increasing decentralization over three years, scaling to site-less model By Team ABLENovartis has announced an additional strategic alliance with Science 37, which is involved in decentralized clinical trial technology and design, to initiate up to 10 new clinical trials over the next three years. The studies will blend virtual and trad

Read more

Evotec, Sanofi intend to create an Evotec-led Infectious Disease Open Innovation R&D Platform

2018-03-11 23:44:35

The Evotec-led platform is open to academia, biotechnology and pharmaceutical companies, foundations, and government agenciesBy Team ABLEGermany’s Evotec AG and Sanofi have entered into exclusive negotiations for Evotec to accelerate infectious disease research and development through a new open innovation platform near Lyon, France.In support of this platform, Sanofi will licence most of its in

Read more

Lupin signs agreement with CSIR-NCL and DST

2018-03-11 23:43:40

Lupin has signed an agreement with CSIR-National Chemical Laboratory and Department of Science and Technology for conducting research on a continuous purification process development of a biosimilar monoclonal antibody therapeutic.By Team ABLEPharma major Lupin has signed an agreement with CSIR-National Chemical Laboratory (CSIR-NCL, Pune) and Department of Science and Technology, (DST, Delhi) for

Read more